This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
Positive opinion for abiraterone acetate to include earlier stage prostate cancer patients
Positive opinion for abiraterone acetate to include earlier stage prostate cancer patients
Read more
NICE recommends access to drug for chronic lymphocytic leukaemia
NICE recommends access to drug for chronic lymphocytic leukaemia
Read more
Positive opinion for PARP 1/2 inhibitor in Europe
Positive opinion for PARP 1/2 inhibitor in Europe
Read more
Treatment of heart attack patients depends on history of cancer
Treatment of heart attack patients depends on history of cancer
Read more
Simple blood test opens door to new treatments for lung cancer patients
Simple blood test opens door to new treatments for lung cancer patients
Read more
Study evaluates utility of Masimo SpHb® during high-blood loss oncosurgery
Study evaluates utility of Masimo SpHb® during high-blood loss oncosurgery
Read more
Tivozanib now licensed in the European Union for first-line treatment
Tivozanib now licensed in the European Union for first-line treatment
Read more
Survival results from carfilzomib Phase III head-to-head trial published
Survival results from carfilzomib Phase III head-to-head trial published
Read more
NICE decision following EU licensing for Kisqali awaited
NICE decision following EU licensing for Kisqali awaited
Read more
Update on good risk acute myeloid leukaemia
Read more
Targeted therapies in CD30+ malignancies
Read more
Preventing exposure to cytotoxic drugs
Read more
Lutetium oxodotreotide recommended for treatment of GEP NETs
Lutetium oxodotreotide recommended for treatment of GEP NETs
Read more
Positive opinion for avelumab for the treatment of metastatic Merkel cell carcinoma
Positive opinion for avelumab for the treatment of metastatic Merkel cell carcinoma
Read more
Candidate metabolomic network for bladder cancer diagnostics
Candidate metabolomic network for bladder cancer diagnostics
Read more
NICE approves cabozantinib for patients with advanced renal cell carcinoma
NICE approves cabozantinib for patients with advanced renal cell carcinoma
Read more
Ethicon launches power stapler enabling extra control and precision for complex surgeries
Read more
Positive opinion for tivozanib for the first-line treatment of advanced renal cell carcinoma in the EU
Positive opinion for tivozanib for the first-line treatment of advanced renal cell carcinoma in the EU
Read more

Popular articles

Genetic link between pancreatitis risk and GLP-1 medicines to be investigated
Research, consensus and progress in fighting TB: ESCMID Global insights
Patient access to trusted health information a focus of NHS 10-year plan



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x